MicroRNA-26a is a novel regulator of vascular smooth muscle cell function

Journal of Cellular Physiology

Volumn 226, Issue 4, 2011, Pages 1035-1043

  Leeper, Nicholas J ^a   Raiesdana, Azad ^a   Kojima, Yoko ^a   Chun, Hyung J ^a   Azuma, Junya ^a   Maegdefessel, Lars ^a   Kundu, Ramendra K ^a   Quertermous, Thomas ^a   Tsao, Philip S ^a   Spin, Joshua M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; MICRORNA; MICRORNA 26A; SMAD PROTEIN; SMAD1 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANEURYSM; ANIMALS; APOLIPOPROTEINS E; APOPTOSIS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CULTURE MEDIA, SERUM-FREE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; MICE; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; SIGNAL TRANSDUCTION; SMAD1 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 79251520968     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22422     Document Type: Article

References (42)

1. Ailawadi G, Moehle CW, Pei H, Walton SP, Yang Z, Kron IL, Lau CL, Owens GK. 2009. Smooth muscle phenotypic modulation is an early event in aortic aneurysms. J Thorac Cardiovasc Surg 138:1392-1399.
2. Asli NS, Pitulescu ME, Kessel M. 2008. MicroRNAs in organogenesis and disease. Curr Mol Med 8:698-710.
3. Azuma J, Asagami T, Dalman R, Tsao PS. 2009. Creation of murine experimental abdominal aortic aneurysms with elastase. J Vis Exp.
4. Boettger T, Beetz N, Kostin S, Schneider J, Kruger M, Hein L, Braun T. 2009. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest 119:2634-2647.
5. Cai X. 2006. Regulation of smooth muscle cells in development and vascular disease: Current therapeutic strategies. Expert Rev Cardiovasc Ther 4:789-800.
6. Chun HJ, Ali ZA, Kojima Y, Kundu RK, Sheikh AY, Agrawal R, Zheng L, Leeper NJ, Pearl NE, Patterson AJ, Anderson JP, Tsao PS, Lenardo MJ, Ashley EA, Quertermous T. 2008. Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis. J Clin Invest 118:3343-3354.
7. Ciarapica R, Russo G, Verginelli F, Raimondi L, Donfrancesco A, Rota R, Giordano A. 2009. Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma. Cell Cycle 8:172-175.
8. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. 2009. Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem 284:3728-3738.
9. Doran AC, Meller N, McNamara CA. 2008. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 28:812-819.
10. Erl W, Hristov M, Neureuter M, Yan ZQ, Hansson GK, Weber PC. 2003. HMG-CoA reductase inhibitors induce apoptosis in neointima-derived vascular smooth muscle cells. Atherosclerosis 169:251-258.
11. Fager G, Hansson GK, Gown AM, Larson DM, Skalli O, Bondjers G. 1989. Human arterial smooth muscle cells in culture: Inverse relationship between proliferation and expression of contractile proteins. In Vitro Cell Dev Biol 25:511-520.
12. Fazi F, Nervi C. 2008. MicroRNA: Basic mechanisms and transcriptional regulatory networks for cell fate determination. Cardiovasc Res 79:553-561.
13. Friedman RC, Farh KK, Burge CB, Bartel DP. 2009. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19:92-105.
14. Gartel AL, Kandel ES. 2008. miRNAs: Little known mediators of oncogenesis. Semin Cancer Biol 18:103-110.
15. Henderson EL, Geng YJ, Sukhova GK, Whittemore AD, Knox J, Libby P. 1999. Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation 99:96-104.
16. Hoshina K, Koyama H, Miyata T, Shigematsu H, Takato T, Dalman RL, Nagawa H. 2004. Aortic wall cell proliferation via basic fibroblast growth factor gene transfer limits progression of experimental abdominal aortic aneurysm. J Vasc Surg 40:512-518.
17. Huang da W, Sherman BT, Tan Q, Collins JR, Alvord WG, Roayaei J, Stephens R, Baseler MW, Lane HC, Lempicki RA. 2007. The DAVID Gene Functional Classification Tool: A novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol 8:R183.
18. Huang da W, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57.
19. Huse JT, Brennan C, Hambardzumyan D, Wee B, Pena J, Rouhanifard SH, Sohn-Lee C, le Sage C, Agami R, Tuschl T, Holland EC. 2009. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev 23:1327-1337.
20. Inoue T, Node K. 2009. Molecular basis of restenosis and novel issues of drug-eluting stents. Circ J 73:615-621.
21. Ishida N, Hayashi K, Hattori A, Yogo K, Kimura T, Takeya T. 2006. CCR1 acts downstream of NFAT2 in osteoclastogenesis and enhances cell migration. J Bone Miner Res 21:48-57.
22. Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C. 2007. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 100:1579-1588.
23. Kong W, Zhao JJ, He L, Cheng JQ. 2009. Strategies for profiling microRNA expression. J Cell Physiol 218:22-25.
24. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, Mendell JR, Mendell JT. 2009. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137:1005-1017.
25. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N. 2005. Combinatorial microRNA target predictions. Nat Genet 37:495-500.
26. Li Z, Hassan MQ, Volinia S, van Wijnen AJ, Stein JL, Croce CM, Lian JB, Stein GS. 2008. A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci USA 105:13906-13911.
27. Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C. 2009. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 104:476-487.
28. Luzi E, Marini F, Sala SC, Tognarini I, Galli G, Brandi ML. 2008. Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. J Bone Miner Res 23:287-295.
29. McDonald OG, Owens GK. 2007. Programming smooth muscle plasticity with chromatin dynamics. Circ Res 100:1428-1441.
30. Owens GK. 1995. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 75:487-517.
31. Owens GK, Loeb A, Gordon D, Thompson MM. 1986. Expression of smooth muscle-specific alpha-isoactin in cultured vascular smooth muscle cells: Relationship between growth and cytodifferentiation. J Cell Biol 102:343-352.
32. Pollman MJ, Naumovski L, Gibbons GH. 1999. Vascular cell apoptosis: Cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cells. Circulation 99:2019-2026.
33. Sander S, Bullinger L, Wirth T. 2009. Repressing the repressor: A new mode of MYC action in lymphomagenesis. Cell Cycle 8:556-559.
34. Sho E, Sho M, Nanjo H, Kawamura K, Masuda H, Dalman RL. 2005. Comparison of cell-type-specific vs. transmural aortic gene expression in experimental aneurysms. J Vasc Surg 41:844-852.
35. Spin JM, Hsu M, Azuma J, Tsao PS. 2009. Transcriptional profiling and network analysis of the murine angiotensin II-induced abdominal aortic aneurysm model; 2009; Omni Shoreham Hotel, Washington, DC. e112.
36. Thompson RW, Liao S, Curci JA. 1997. Vascular smooth muscle cell apoptosis in abdominal aortic aneurysms. Coron Artery Dis 8:623-631.
37. Tusher VG, Tibshirani R, Chu G. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121.
38. Urbich C, Kuehbacher A, Dimmeler S. 2008. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 79:581-588.
39. Van Vickle-Chavez SJ, Tung WS, Absi TS, Ennis TL, Mao D, Cobb JP, Thompson RW. 2006. Temporal changes in mouse aortic wall gene expression during the development of elastase-induced abdominal aortic aneurysms. J Vasc Surg 43:1010-1020.
40. Wong CF, Tellam RL. 2008. MicroRNA-26a targets the histone methyltransferase Enhancer of Zeste homolog 2 during myogenesis. J Biol Chem 283:9836-9843.
41. Yue P, Jin H, Aillaud-Manzanera M, Deng AC, Azuma J, Asagami T, Kundu RK, Reaven GM, Quertermous T, Tsao PS. 2010. Apelin is necessary for the maintenance of insulin sensitivity. Am J Physiol Endocrinol Metab 298:E59-E67.
42. Zhang C. 2009. MicroRNA and vascular smooth muscle cell phenotype: New therapy for atherosclerosis? Genome Med 1:85.